LUIS
BUJANDA FERNÁNDEZ DE PIÉROLA
Fundación Hospital Alcorcón
Alcorcón, EspañaPublikationen in Zusammenarbeit mit Forschern von Fundación Hospital Alcorcón (22)
2024
-
Evaluation of Genetic Variants Associated with the Risk of Thiopurine-Related Pancreatitis: A Case Control Study from ENEIDA Registry
Digestive Diseases, Vol. 42, Núm. 3, pp. 257-264
-
Initial Management of Intra-abdominal Abscesses and Preventive Strategies for Abscess Recurrence in Penetrating Crohn's Disease: A National, Multicentre Study Based on ENEIDA Registry
Journal of Crohn's & colitis, Vol. 18, Núm. 4, pp. 578-588
-
Persistence, effectiveness and safety of ustekinumab and vedolizumab therapy for complex perianal fistula in Crohn's disease: The HEAL study from GETECCU
Digestive and Liver Disease, Vol. 56, Núm. 11, pp. 1845-1853
-
Sex-Related Differences in the Phenotype and Course of Inflammatory Bowel Disease: SEXEII Study of ENEIDA
Clinical Gastroenterology and Hepatology, Vol. 22, Núm. 11, pp. 2280-2290
-
Trends in Targeted Therapy Usage in Inflammatory Bowel Disease: TRENDY Study of ENEIDA
Pharmaceutics, Vol. 16, Núm. 5
2023
-
Effectiveness and Safety of Ustekinumab in Elderly Patients with Crohn's Disease: Real World Evidence From the ENEIDA Registry
Journal of Crohn's & colitis, Vol. 17, Núm. 1, pp. 83-91
-
Long-Term Outcomes of Biological Therapy in Crohn's Disease Complicated with Internal Fistulizing Disease: BIOSCOPE Study from GETECCU
American Journal of Gastroenterology, Vol. 118, Núm. 6, pp. 1036-1046
2022
-
Immigrant IBD Patients in Spain Are Younger, Have More Extraintestinal Manifestations and Use More Biologics Than Native Patients
Frontiers in Medicine, Vol. 9
-
Nationwide COVID-19-EII Study: Incidence, Environmental Risk Factors and Long-Term Follow-Up of Patients with Inflammatory Bowel Disease and COVID-19 of the ENEIDA Registry
Journal of Clinical Medicine, Vol. 11, Núm. 2
-
Performance of Screening Strategies for Latent Tuberculosis Infection in Patients with Inflammatory Bowel Disease: Results from the ENEIDA Registry of GETECCU
Journal of Clinical Medicine, Vol. 11, Núm. 13
-
Risk Factors for COVID-19 in Inflammatory Bowel Disease: A National, ENEIDA-Based Case–Control Study (COVID-19-EII)
Journal of Clinical Medicine, Vol. 11, Núm. 24
2021
-
Extraintestinal Manifestations in Patients with Inflammatory Bowel Disease: Study Based on the ENEIDA Registry
Digestive Diseases and Sciences, Vol. 66, Núm. 6, pp. 2014-2023
2019
-
Clinical Characteristics, Associated Malignancies and Management of Primary Sclerosing Cholangitis in Inflammatory Bowel Disease Patients: A Multicentre Retrospective Cohort Study
Journal of Crohn's & colitis, Vol. 13, Núm. 12, pp. 1492-1500
2018
-
Importance of endoscopist quality metrics for findings at surveillance colonoscopy: The detection-surveillance paradox
United European Gastroenterology Journal, Vol. 6, Núm. 4, pp. 622-629
2017
-
Prevalence of malnutrition and nutritional characteristics of patients with inflammatory bowel disease
Journal of Crohn's and Colitis, Vol. 11, Núm. 12, pp. 1430-1439
2016
-
Endoscopist characteristics that influence the quality of colonoscopy
Endoscopy, Vol. 48, Núm. 3, pp. 241-247
2014
-
Effect of oral anticoagulants on the outcome of faecal immunochemical test
British Journal of Cancer, Vol. 110, Núm. 5, pp. 1334-1337
2013
-
Effect of aspirin and antiplatelet drugs on the outcome of the fecal immunochemical test
Mayo Clinic Proceedings
-
Modifiable endoscopic factors that influence the adenoma detection rate in colorectal cancer screening colonoscopies
Gastrointestinal Endoscopy, Vol. 77, Núm. 3
-
Relationship of colonoscopy-detected serrated polyps with synchronous advanced neoplasia in average-risk individuals
Gastrointestinal Endoscopy, Vol. 78, Núm. 2